Effect of Combined Spironolactone–β-Blocker ± Enalapril Treatment on Occurrence of Symptomatic Atrial Fibrillation Episodes in Patients With a History of Paroxysmal Atrial Fibrillation (SPIR-AF Study)
- 1 December 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (11) , 1609-1614
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Evidence for an increased rate of cardiovascular events in patients with primary aldosteronismJACC, 2005
- Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical dataAmerican Heart Journal, 2004
- Aldosterone-induced cardiac damage: focus on blood pressure independent effectsAmerican Journal of Hypertension, 2003
- Aldosterone: Cardiovascular assaultAmerican Heart Journal, 2002
- Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillationThe American Journal of Cardiology, 2001
- Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat CardiocytesCirculation, 2001
- Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillationJACC, 2000
- Selective Downregulation of the Angiotensin II AT1-Receptor Subtype in Failing Human Ventricular MyocardiumCirculation, 1997
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase CJournal of Autonomic Pharmacology, 1991